These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1880157)

  • 21. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
    Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759
    [No Abstract]   [Full Text] [Related]  

  • 24. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
    Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC
    Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass.
    Donahue BS; Gailani D; Mast AE
    J Thromb Haemost; 2006 May; 4(5):1011-6. PubMed ID: 16689752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
    Chu AJ; Wang ZG; Fox MJ
    Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
    Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
    Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
    Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor.
    Lindahl AK; Abildgaard U; Staalesen R
    Thromb Res; 1991 Oct; 64(2):155-68. PubMed ID: 1811336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
    Hansen JB; Olsen JO; Osterud B
    Thromb Haemost; 1990 Aug; 64(1):124-6. PubMed ID: 2274917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.
    Nordfang O; Bjørn SE; Valentin S; Nielsen LS; Wildgoose P; Beck TC; Hedner U
    Biochemistry; 1991 Oct; 30(43):10371-6. PubMed ID: 1931960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).
    Sandset PM; Abildgaard U; Larsen ML
    Thromb Res; 1988 Jun; 50(6):803-13. PubMed ID: 3413731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.
    Novotny WF; Palmier M; Wun TC; Broze GJ; Miletich JP
    Blood; 1991 Jul; 78(2):394-400. PubMed ID: 2070077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 40. cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor.
    Wesselschmidt RL; Girard TJ; Broze GJ
    Nucleic Acids Res; 1990 Nov; 18(21):6440. PubMed ID: 2136251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.